NewsRx

Search our medical news database

Cancer Vaccines

DNA and hepatitis B virus vaccine evaluated in colorectal cancer patients

Published in Vaccine Weekly, October 9th, 2002

by Sonia Nichols, senior medical writer - The jury is still out on whether or not DNA vaccines are effective cancer fighters.

"Despite an abundance of preclinical data, relatively little is known regarding the efficacy of DNA vaccination in humans," the authors of a recent University of Alabama at Birmingham vaccine trial pointed out.

Patients given a plasmid-encoded vaccine combining hepatitis B surface antigen (HBsAg) and carcinoembryonic antigen (CEA) responded well to the vaccine's viral antigen, but showed little clinical response to the cancer antigen, according to Robert M. Conry and coauthors, who are investigators in the Divisions of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook